Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system. Catalyst’s reverse shoulder system is a single-tray arthroplasty system that is made to combine beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The
Stryker has announced it has cleared all regulatory hurdles previously in the way of its planned $4.7 billion acquisition of Wright Medical. The tender offer was initiated back in November 2019 and has now been completed as of November 11, 2020. “Wright Medical has built a successful business, and together we look forward to working
Anika Therapeutics, Inc. announced that the WristMotion Total Arthroplasty System received 510(k) clearance from the U.S. Food and Drug Administration. The WristMotion System is used in procedures to replace painful wrist joints due to rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis, allowing a patient to maintain native biomechanics. This replacement implant is an entirely new approach
Smith+Nephew (LSE:SN, NYSE:SNN) have announced that they have an agreement to acquire the Extremity Orthopedics business of Integra LifeSciences Holdings Corporation (NASDAQ:IART) for $240 million. Smith+Nephew noted that the portfolio includes devices, implants and instruments designed for shoulder replacement and reconstruction of bones in the hand, wrist and elbow, as well as the foot and
In2Bones launches Avenger Radial Head Prosthesis System for primary and revision radial head replacement surgery. The prosthesis, which restores elbow joint function, is the first radial head implant to include sterile, single-use instrumentation. Severe radial head fractures, commonly resulting from elbow trauma, require radial head replacement surgery. Single-use instrumentation is much more readily available for
In2Bones, a global extremity company, receives FDA 510(k) clearance for its Quantum Total Ankle. The ankle replacement is designed to improve the mobility and stability for patients suffering from arthritis. The implant’s talus has a dual radius of curvature which improves dorsi and plantar flexion. Unlike other total ankles, the vertical stem in the tibia
Coventus Orthopaedics, Inc., a medical device company whose focus is on continuous development of fracture treatment, announced this month that they have acquired all the assets of IntraFuse, LLC. IntraFuse has developed proprietary intramedullary implants for minimally invasive repair of bone fractures and are known for their FlexThread impants, which are FDA cleared and protected
Register to receive a free Small Bone and Joint Devices Market Analysis, Size, and Trends Report synopsis and brochure. During a press release, there was a massive development in the small bone and joints market, where Wright Medical sold all issued and outstanding ordinary shares of the company to the Stryker Corporation. The agreement between
Register to receive a free Small Bone and Joint Market Analysis, Size, and Trends Report synopsis and brochure. As a commitment to innovating the foot and ankle market, Exactech has developed the Vantage Ankle Flat Cut Talus. This new alternative talus implant solution for patients addresses the issue of preserving the talar dome. Dr. Samuel
Register to receive a free synopsis and brochure. Browse the Report Library. Arthrex is a global medical company focused in orthopedic product development and education, and was founded in 1981. Today it is a privately held organization headquartered in Southwest Florida. Arthrex has an additional global division in Germany and several subsidiaries and distribution centers in Europe,
